NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

Patients with primary biliary cholangitis (PBC) who had an inadequate response to ursodiol have few treatment options. Alkaline phosphatase (ALP) and bilirubin levels correlate with the risk of liver transplant or death in PBC patients. Fibroblast growth factor (FGF) 19 is a hormone that acts direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayo, Marlyn J., Wigg, Alan J., Leggett, Barbara A., Arnold, Hays, Thompson, Alexander J., Weltman, Martin, Carey, Elizabeth J., Muir, Andrew J., Ling, Lei, Rossi, Stephen J., DePaoli, Alex M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128239/
https://www.ncbi.nlm.nih.gov/pubmed/30202819
http://dx.doi.org/10.1002/hep4.1209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128239/
https://www.ncbi.nlm.nih.gov/pubmed/30202819
http://dx.doi.org/10.1002/hep4.1209

Ejemplares similares